ClinConnect ClinConnect Logo
Search / Trial NCT06884397

Use of Artificial Intelligence to Predict Complications Following Abdominal Aortic Surgery

Launched by GROUPE HOSPITALIER DE LA ROCHELLE RÉ AUNIS · Mar 13, 2025

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Aortic Aneurysm, Abdominal Prostheses And Implants Endoleak Angiography, Computed Tomography Machine Learning Algorithm

ClinConnect Summary

This clinical trial is looking into how artificial intelligence (AI) can help predict complications after a specific type of surgery for abdominal aortic aneurysms (AAA). An AAA is when the aorta, the large blood vessel that carries blood from the heart to the rest of the body, becomes enlarged. One way to treat this condition is by using a less invasive method called endovascular surgery, where a special device is placed inside the aorta through a small incision. While this method is promising, doctors want to ensure that there are no leaks from the device after surgery. Researchers are exploring the use of AI to automatically analyze medical images for signs of potential leaks, which could help doctors monitor patients more effectively.

To be eligible for this trial, participants should be between the ages of 65 and 74 and must have received treatment for an abdominal aortic aneurysm using the endovascular method. Certain patients, such as those who had specific additional procedures during surgery or who do not want their data used in the study, will not be included. If someone joins the trial, they can expect to help researchers understand how AI can improve patient care by providing insights based on their medical images. This study is an exciting step towards better monitoring and outcomes for patients who have undergone this type of surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Treated for an abdominal aortic aneurysm through endovascular prosthesis implantation
  • Exclusion Criteria:
  • Underwent intraoperative embolization of the inferior mesenteric artery or aneurysmal sac
  • Refuse the use of their data

About Groupe Hospitalier De La Rochelle Ré Aunis

Groupe Hospitalier de La Rochelle Ré-Aunis is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. Located in La Rochelle, France, this multidisciplinary hospital group encompasses several facilities that provide comprehensive healthcare services while fostering innovation in clinical practices. With a strong commitment to excellence in patient care and a collaborative approach to research, the group actively participates in clinical trials aimed at exploring new therapies and enhancing treatment modalities across various medical fields. Their focus on patient-centered research underscores their dedication to integrating scientific advancements into everyday clinical settings.

Locations

La Rochelle, , France

Patients applied

0 patients applied

Trial Officials

Sébastien Franco, MD

Study Director

Groupe Hospitalier de la Rochelle Ré Aunis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported